Queen Street Partners Invests in CNS Response

Toronto, Ontario Canada – January 2011

As the first Canadian Institutional investor, Queen Street Partners brings awareness to the U.S. based life sciences company CNS Response. CNS Response is an online neuroinformatic company that develops reference data and analytic tools for clinicians and researchers, based on a novel neurometric technology called Referenced-EEGĀ®.

The company has two distinct business segments, one of which utilizes a patented system that guides psychiatrists and other physicians to determine a proper treatment for patients with mental, behavioural and/or addictive disorders. CNS Response also intends to identify, develop and commercialize new indications of approved drugs ad drug candidates for the patient population.

According to the Center for Addiction and Mental Health, 1 in 5 Canadians will experience a mental illness in their lifetime, with Schizophrenia affecting 1%, and major Depression affecting 8% of the population. Queen Street Partners is also an active supporter of a variety of charitable organizations.

This entry was posted in News. Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>


Our Firm

Queen Street Partners is an investment, development, and management company based in Toronto, Canada.

Our Strategy

We value good Partnerships. Approach business with creativity and navigate the path to success.

Our Focus

Cultivating talent & recognizing value in our relationships.

Our Value

Vision and execution.
Copyright © 2008-2018 Queen Street Partners